Skip to main content
BAXTER INTERNATIONAL INC logo

BAXTER INTERNATIONAL INC — Investor Relations & Filings

Ticker · BAX ISIN · US0718131099 LEI · J5OIVXX3P24RJRW5CK77 US Manufacturing
Open in API
Filings indexed 2,456 across all filing types
Latest filing 2020-11-06 Capital/Financing Update
Country US United States of America
Listing US BAX

About BAXTER INTERNATIONAL INC

https://www.baxter.com/

Baxter International Inc. is a global healthcare company focused on saving and sustaining lives. The company provides a broad portfolio of essential products across renal care, hospital, and surgical settings. Key offerings include technologies for acute and chronic dialysis, sterile intravenous (IV) solutions, infusion systems, clinical nutrition, and critical care. Baxter develops, manufactures, and markets a range of medical devices, connected care solutions, and advanced injectable pharmaceuticals. The company's products are used by healthcare professionals in hospitals, clinics, and homes to provide smarter, more personalized care for patients.

Recent filings

Filing Released Lang Actions
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The content includes details about a material definitive agreement (a Second Supplemental Indenture related to senior notes issuance and redemption), creation of a direct financial obligation, and Regulation FD disclosure about earnings guidance updates. It does not contain comprehensive financial statements or detailed financial performance data typical of Annual Reports (10-K) or Interim Reports (IR). It is not an earnings release (ER) since it provides guidance updates and debt issuance details rather than initial quarterly results. The document is lengthy (15,000 characters) and contains substantive information about financing activities, specifically the issuance of senior notes and related agreements. This fits the definition of a Capital/Financing Update (CAP).
2020-11-06 English
PRIMARY DOCUMENT
Director's Dealing
2020-11-04 English
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated October 29, 2020. It announces a proposed offering of $650 million senior notes due 2031 in a private placement and discusses the intended use of proceeds to redeem existing notes. The document includes a press release as an exhibit and contains forward-looking statements. There are no financial statements or detailed financial data presented, nor is this a full annual or quarterly report. The content focuses on a capital raising event and financing update. Therefore, the document fits the category of Capital/Financing Update (CAP). The document length is 5682 characters, sufficient to contain substantive information about the financing event rather than just an announcement of a report publication or a regulatory filing. Hence, the classification is CAP with high confidence.
2020-10-29 English
10-Q
Interim / Quarterly Report Q3 2020
2020-10-29 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated October 29, 2020, by Baxter International Inc. It reports the issuance of an earnings press release for the period ended September 30, 2020. The document explicitly states that the press release is furnished as an exhibit and is described as an earnings press release. The length of the document is 3302 characters, which is relatively short and primarily serves as an announcement of the earnings release rather than containing detailed financial statements or analysis itself. According to the rules, initial announcements of quarterly or periodical financial results (key highlights only) are classified as Earnings Release (ER). Therefore, this document is best classified as an Earnings Release (ER).
2020-10-29 English
8-K
Regulatory Filings Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a Current Report pursuant to the Securities Exchange Act of 1934. It reports a specific event: the withdrawal of FDA 510(k) applications for a medical device and plans for resubmission. The document does not contain comprehensive financial statements or detailed financial analysis, but rather a disclosure of a material event affecting the company. It is not an Annual Report, Interim Report, Earnings Release, or any other detailed financial report. It is a regulatory filing reporting a material event, which fits the category of Regulatory Filings (RNS). The document length is about 5,421 characters, which is consistent with a typical 8-K filing. Therefore, the appropriate classification is Regulatory Filings (RNS).
2020-10-08 English

Browse filings by year

33 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.